828 WINTER STREET, WALTHAM, MA
Director Resignation and Re-Appointment - Daniel Curran, M.D.
Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
Annual Report to Security Holders
Cheryl R. Blanchard Elected as Director and Compensation Committee Chair
Financial Results, Press Release
Announces 1-for-14 Reverse Stock Split
Investor Presentation
Stockholders Approve Reverse Stock Split Proposal at Special Meeting
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence
Submission Upload